PAD Awareness Month calls attention to amputation risks, screening, treatments
September is Peripheral Artery Disease Awareness Month, designed to improve access to screening and treatments for patients with PAD.
According to the CardioVascular Coalition, approximately 20 million Americans have PAD, and about 200,000 patients per year undergo avoidable amputations. Many of these patients are from historically underrepresented backgrounds, according to the coalition.
As part of this year’s PAD Awareness Month activities, the coalition is calling for Congress to block planned cuts to Medicare specialty providers, including vascular surgeons, cardiac surgeons and interventional radiologists, all of whom treat PAD.
To commemorate PAD Awareness Month, Healio and Cardiology Today have compiled a list of recent PAD-related news.
VOYAGER PAD: Treatment effect of rivaroxaban in PAD strongest in concomitant CAD
Among patients with PAD who underwent revascularization, those with concomitant clinical evidence of CAD received greater absolute benefit of reduced risk for MACE from taking low-dose rivaroxaban than those with PAD without CAD. Read more
Depressive symptoms may worsen health status in PAD
Women with PAD were more likely to have depressive symptoms compared with men, researchers found. Read more
CV medications underused by Hispanic/Latino patients with PAD
Hispanic and Latino patients with PAD underuse guideline-recommended CV medications such as antiplatelet and lipid-lowering therapies, researchers found. Read more
Statin therapy less common in PAD than CHD, cerebrovascular disease
Patients with PAD were less likely to be treated with statin therapy compared with those with cerebrovascular disease or CHD despite having a high risk for atherosclerotic CVD events, researchers found. Read more
Diabetes, CLI among factors connected to major amputation in PAD
In an analysis of the EUCLID trial, factors associated with major amputation in PAD included diabetes, prior amputation, critical limb ischemia and an ankle-brachial index of less than 0.8. Read more
ACC, SVS collaborate on registry to improve care of vascular disease
The American College of Cardiology announced a collaboration with the Society for Vascular Surgery focused on a single vascular registry to improve outcomes and care for patients with vascular disease. Read more
Paclitaxel-related mortality risk not observed in Medicare Advantage cohort
In a retrospective, adjusted analysis of Medicare Advantage beneficiaries who underwent peripheral vascular interventions, there was no evidence of an elevated mortality risk due to paclitaxel-coated devices. Read more
Chronic stress after new, worsening PAD diagnosis predicts long-term mortality
Among patients with new or worsening PAD, chronic stress was independently associated with elevated risk for all-cause mortality in the subsequent 4 years, researchers reported. Read more
SCAI advises on optimal device use in aortoiliac interventions
The Society for Cardiovascular Angiography and Interventions released guidelines on selection of devices for aortoiliac arterial interventions. Read more
Alcohol consumption increases risk for PAD, stroke
Higher alcohol consumption predicted by genetics was associated with elevated risk for peripheral artery disease and stroke, according to a study published in Circulation: Genomic and Precision Medicine. Read more